This inventor holds 3 USPTO granted patents. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1987-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1990
Title: Morinobu Saito: Innovator in Medicinal Chemistry
Introduction
Morinobu Saito is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as lipoxygenase inhibitors. With a total of three patents to his name, Saito's work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Saito's latest patents include innovative compounds that demonstrate medicinal properties. One of his notable inventions is the 2-(3,5-dimethyl-4-hydroxyphenyl)indole derivatives. This compound is characterized by a specific formula where R1 can be a hydrogen atom or a methoxy group, and A represents a C1-C4 alkylene group. This compound is particularly useful as a medicine, especially as a lipoxygenase inhibitor for polyunsaturated fatty acids. Another significant patent is the 2-(3,5-dialkyl-4-hydroxyphenyl)indole derivatives. This compound has a complex structure and exhibits 5-lipoxygenase inhibiting activity, making it valuable as a medicament.
Career Highlights
Morinobu Saito is currently associated with Teikoku Hormone Mfg. Co., Ltd., where he continues to innovate in the field of medicinal chemistry. His work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Saito has collaborated with notable colleagues, including Yasushi Suzuki and Yukio Hasegawa. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Morinobu Saito's contributions to medicinal chemistry through his innovative patents highlight his role as a significant inventor in the field. His work on lipoxygenase inhibitors showcases the potential for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile